125 related articles for article (PubMed ID: 16080811)
1. [Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome].
Qin Q; Zhao BR; Mao YM; Cui RZ; Kou L; Li YL; Zhao FM; Hui RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):622-6. PubMed ID: 16080811
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
[TBL] [Abstract][Full Text] [Related]
3. A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome.
Tian C; Qin W; Li L; Zheng W; Qiu F
Biomed Pharmacother; 2010 Mar; 64(3):191-4. PubMed ID: 20137882
[TBL] [Abstract][Full Text] [Related]
4. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
[TBL] [Abstract][Full Text] [Related]
5. Positive correlation between CD137 expression and complex stenosis morphology in patients with acute coronary syndromes.
Yan J; Gong J; Liu P; Wang C; Chen G
Clin Chim Acta; 2011 May; 412(11-12):993-8. PubMed ID: 21396356
[TBL] [Abstract][Full Text] [Related]
6. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
[TBL] [Abstract][Full Text] [Related]
7. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
8. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
Koh YS; Chang K; Kim PJ; Seung KB; Baek SH; Shin WS; Lim SH; Kim JH; Choi KB
Int J Cardiol; 2008 Jul; 127(3):430-2. PubMed ID: 17698228
[TBL] [Abstract][Full Text] [Related]
9. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).
Bigalke B; Stellos K; Weig HJ; Geisler T; Seizer P; Kremmer E; Pötz O; Joos T; May AE; Lindemann S; Gawaz M
Basic Res Cardiol; 2009 May; 104(3):352-7. PubMed ID: 19190951
[TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain.
Bigalke B; Haap M; Stellos K; Geisler T; Seizer P; Kremmer E; Overkamp D; Gawaz M
Thromb Res; 2010 May; 125(5):e184-9. PubMed ID: 20122713
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L;
Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489
[TBL] [Abstract][Full Text] [Related]
12. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
13. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
Gao B; Li ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K
Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
[TBL] [Abstract][Full Text] [Related]
15. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
Gai X; Lan X; Luo Z; Wang F; Liang Y; Zhang H; Zhang W; Hou J; Huang M
Clin Chim Acta; 2009 Oct; 408(1-2):105-9. PubMed ID: 19665460
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
17. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes.
Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y
Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965
[TBL] [Abstract][Full Text] [Related]
18. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
[TBL] [Abstract][Full Text] [Related]
19. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
Wang Y; Su Y; Xu Y; Pan SH; Liu GD
Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
